Triple-combination therapy prevents drug resistance in colorectal cancer cells

Treating colorectal cancer  with a trio of targeted drugs reduces the acquisition of drug resistance, in vitro research published in Oncogene shows.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research